Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyps mystery

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyps mystery

Type 2 Inflammation Is The Underlying Cause Of Crswnp In 80% Of Patients.

Type 2 Inflammation Is The Underlying Cause Of Crswnp In 80% Of Patients.

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

Maternal and Perinatal Outcomes of VTE

Maternal and Perinatal Outcomes of VTE

Atopic Dermatitis story

Atopic Dermatitis story

Use of Lipid-Lowering Therapies Over 2 Years

Use of Lipid-Lowering Therapies Over 2 Years

The European experience: Swedeheart and AIFA registries

The European experience: Swedeheart and AIFA registries

Perceptions and Barriers on the use of PCSK9 inhibitors

Perceptions and Barriers on the use of PCSK9 inhibitors

Recurrence of VTE in Patients with Recent Gestational DVT or PE

Recurrence of VTE in Patients with Recent Gestational DVT or PE

How does Dupixent support lung function improvement in Pediatric Asthma?

How does Dupixent support lung function improvement in Pediatric Asthma?

Prognostic impact of achieving LDL cholesterol guidelines

Prognostic impact of achieving LDL cholesterol guidelines